{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:30:14Z","timestamp":1786491014274,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH073, ZR2023MC127"],"award-info":[{"award-number":["ZR2024QH073, ZR2023MC127"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902994, 82172970, 31771526"],"award-info":[{"award-number":["81902994, 82172970, 31771526"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75155-w","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T06:15:35Z","timestamp":1782972935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["TMEM216 inhibits breast cancer lung metastasis by modulating IGF1R-IRS4 signaling pathway"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2124-2650","authenticated-orcid":false,"given":"Yingying","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zirui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-1268","authenticated-orcid":false,"given":"Xiaoyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7008-0550","authenticated-orcid":false,"given":"Ling","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1879-3817","authenticated-orcid":false,"given":"Xiangguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"75155_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"75155_CR2","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41392-024-01885-2","volume":"9","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. Mechanism insights and therapeutic intervention of tumor metastasis: latest developments and perspectives. Signal Transduct. Target Ther. 9, 192 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"75155_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser, K. E. & Joyce, J. A. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41, 374\u2013403 (2023).","journal-title":"Cancer Cell"},{"key":"75155_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s43018-022-00491-x","volume":"4","author":"S Garcia-Recio","year":"2022","unstructured":"Garcia-Recio, S. et al. Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis. Nat. Cancer 4, 128\u2013147 (2022).","journal-title":"Nat. Cancer"},{"key":"75155_CR5","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1038\/s41388-022-02376-w","volume":"41","author":"E Alfaro-Arnedo","year":"2022","unstructured":"Alfaro-Arnedo, E. et al. IGF1R acts as a cancer-promoting factor in the tumor microenvironment, facilitating lung metastasis implantation and progression. Oncogene 41, 3625\u20133639 (2022).","journal-title":"Oncogene"},{"key":"75155_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111759","volume":"41","author":"JS Lee","year":"2022","unstructured":"Lee, J. S. et al. The insulin and IGF signaling pathway sustains breast cancer stem cells by IRS2\/PI3K-mediated regulation of MYC. Cell Rep. 41, 111759 (2022).","journal-title":"Cell Rep."},{"key":"75155_CR7","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","volume":"42","author":"CS McGinnis","year":"2024","unstructured":"McGinnis, C. S. et al. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell 42, 1018\u20131031.e1016 (2024).","journal-title":"Cancer Cell"},{"key":"75155_CR8","doi-asserted-by":"publisher","first-page":"e03772","DOI":"10.7554\/eLife.03772","volume":"3","author":"JM Kavran","year":"2014","unstructured":"Kavran, J. M. et al. How IGF-1 activates its receptor. Elife 3, e03772 (2014).","journal-title":"Elife"},{"key":"75155_CR9","doi-asserted-by":"publisher","first-page":"911079","DOI":"10.3389\/fendo.2022.911079","volume":"13","author":"JJ Bulatowicz","year":"2022","unstructured":"Bulatowicz, J. J. & Wood, T. L. Activation versus inhibition of IGF1R: a dual role in breast tumorigenesis. Front. Endocrinol. 13, 911079 (2022).","journal-title":"Front. Endocrinol."},{"key":"75155_CR10","doi-asserted-by":"publisher","unstructured":"Choi, E., Duan, C. & Bai, X.-c. Regulation and function of insulin and insulin-like growth factor receptor signalling. Nature Reviews Molecular Cell Biology https:\/\/doi.org\/10.1038\/s41580-025-00826-3 (2025).","DOI":"10.1038\/s41580-025-00826-3"},{"key":"75155_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41421-023-00576-6","volume":"9","author":"XK Gao","year":"2023","unstructured":"Gao, X. K. et al. VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin\/IGF signaling. Cell Discov. 9, 83 (2023).","journal-title":"Cell Discov."},{"key":"75155_CR12","doi-asserted-by":"publisher","first-page":"14882","DOI":"10.3390\/ijms241914882","volume":"24","author":"H Werner","year":"2023","unstructured":"Werner, H. The IGF1 signaling pathway: from basic concepts to therapeutic opportunities. Int. J. Mol. Sci. 24, 14882 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"75155_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155620","volume":"263","author":"S Kumar","year":"2024","unstructured":"Kumar, S. & Chaudhri, S. Recent update on IGF-1\/IGF-1R signaling axis as a promising therapeutic target for triple-negative breast cancer. Pathol. Res. Pract. 263, 155620 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"75155_CR14","doi-asserted-by":"publisher","first-page":"9712","DOI":"10.1158\/0008-5472.CAN-08-1952","volume":"68","author":"NK Saxena","year":"2008","unstructured":"Saxena, N. K. et al. Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor. Cancer Res. 68, 9712\u20139722 (2008).","journal-title":"Cancer Res."},{"key":"75155_CR15","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.18632\/oncotarget.3023","volume":"6","author":"L Taliaferro-Smith","year":"2015","unstructured":"Taliaferro-Smith, L. et al. FAK activation is required for IGF1R-mediated regulation of EMT, migration, and invasion in mesenchymal triple-negative breast cancer cells. Oncotarget 6, 4757\u20134772 (2015).","journal-title":"Oncotarget"},{"key":"75155_CR16","doi-asserted-by":"publisher","unstructured":"Guijarro, L. G. et al. Is Insulin Receptor Substrate4 (IRS4) a platform involved in the activation of several oncogenes? Cancers (Basel) https:\/\/doi.org\/10.3390\/cancers15184651 (2023).","DOI":"10.3390\/cancers15184651"},{"key":"75155_CR17","doi-asserted-by":"publisher","first-page":"26302","DOI":"10.1074\/jbc.M114.565945","volume":"289","author":"Y Homma","year":"2014","unstructured":"Homma, Y. et al. Insulin receptor substrate-4 binds to Slingshot-1 phosphatase and promotes cofilin dephosphorylation.  J. Biol. Chem. 289, 26302\u201326313 (2014).","journal-title":"J. Biol. Chem."},{"key":"75155_CR18","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.7150\/thno.26021","volume":"8","author":"X Li","year":"2018","unstructured":"Li, X. et al. Phosphorylation of IRS4 by CK1\u03b32 promotes its degradation by CHIP through the ubiquitin\/lysosome pathway. Theranostics 8, 3643\u20133653 (2018).","journal-title":"Theranostics"},{"key":"75155_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13567","volume":"7","author":"GJ Ikink","year":"2016","unstructured":"Ikink, G. J., Boer, M., Bakker, E. R. & Hilkens, J. IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K\/AKT-pathway hyperactivation. Nat. Commun. 7, 13567 (2016).","journal-title":"Nat. Commun."},{"key":"75155_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s10735-017-9745-0","volume":"49","author":"P Sanmart\u00edn-Salinas","year":"2018","unstructured":"Sanmart\u00edn-Salinas, P., Toledo-Lobo, M. V., Noguerales-Fraguas, F., Fern\u00e1ndez-Contreras, M. E. & Guijarro, L. G. Overexpression of insulin receptor substrate-4 is correlated with clinical staging in colorectal cancer patients. J. Mol. Histol. 49, 39\u201349 (2018).","journal-title":"J. Mol. Histol."},{"key":"75155_CR21","doi-asserted-by":"publisher","first-page":"e1279722","DOI":"10.1080\/23723556.2017.1279722","volume":"4","author":"GJ Ikink","year":"2017","unstructured":"Ikink, G. J. & Hilkens, J. Insulin receptor substrate 4 (IRS4) is a constitutively active oncogenic driver collaborating with HER2 and causing therapeutic resistance. Mol. Cell. Oncol. 4, e1279722 (2017).","journal-title":"Mol. Cell. Oncol."},{"key":"75155_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/molbev\/mss215","volume":"30","author":"B Venkatesh","year":"2013","unstructured":"Venkatesh, B., Ravi, V., Lee, A. P., Warren, W. C. & Brenner, S. Basal vertebrates clarify the evolutionary history of ciliopathy-associated genes Tmem138 and Tmem216. Mol. Biol. Evol. 30, 62\u201365 (2013).","journal-title":"Mol. Biol. Evol."},{"key":"75155_CR23","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/ng.594","volume":"42","author":"EM Valente","year":"2010","unstructured":"Valente, E. M. et al. Mutations in TMEM216 perturb ciliogenesis and cause Joubert, Meckel and related syndromes. Nat. Genet. 42, 619\u2013625 (2010).","journal-title":"Nat. Genet."},{"key":"75155_CR24","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.61.8.24","volume":"61","author":"Y Liu","year":"2020","unstructured":"Liu, Y., Cao, S., Yu, M. & Hu, H. TMEM216 deletion causes mislocalization of cone opsin and rhodopsin and photoreceptor degeneration in zebrafish. Invest Ophthalmol. Vis. Sci. 61, 24 (2020).","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"75155_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abo0465","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. TMEM216 promotes primary ciliogenesis and Hedgehog signaling through the SUFU-GLI2\/GLI3 axis. Sci. Signal. 17, eabo0465 (2024).","journal-title":"Sci. Signal."},{"key":"75155_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/2046-2530-3-7","volume":"3","author":"I Menzl","year":"2014","unstructured":"Menzl, I. et al. Loss of primary cilia occurs early in breast cancer development. Cilia 3, 7 (2014).","journal-title":"Cilia"},{"key":"75155_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1158\/1541-7786.MCR-17-0034","volume":"15","author":"NB Hassounah","year":"2017","unstructured":"Hassounah, N. B. et al. Inhibition of ciliogenesis promotes hedgehog signaling, tumorigenesis, and metastasis in breast cancer. Mol. cancer Res.: MCR 15, 1421\u20131430 (2017).","journal-title":"Mol. cancer Res.: MCR"},{"key":"75155_CR28","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy, B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput. Struct. Biotechnol. J. 19, 4101\u20134109 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"75155_CR29","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1158\/1055-9965.EPI-17-0627","volume":"27","author":"N Howlader","year":"2018","unstructured":"Howlader, N., Cronin, K. A., Kurian, A. W. & Andridge, R. Differences in breast cancer survival by molecular subtypes in the United States. Cancer Epidemiol. Biomark. Prev. 27, 619\u2013626 (2018).","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"75155_CR30","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.1245\/s10434-021-10227-3","volume":"28","author":"M Taskindoust","year":"2021","unstructured":"Taskindoust, M. et al. Survival outcomes among patients with metastatic breast cancer: review of 47,000 patients. Ann. Surg. Oncol. 28, 7441\u20137449 (2021).","journal-title":"Ann. Surg. Oncol."},{"key":"75155_CR31","doi-asserted-by":"publisher","unstructured":"Bhateja, P., Cherian, M., Majumder, S. & Ramaswamy, B. The Hedgehog signaling pathway: a viable target in breast cancer? Cancers https:\/\/doi.org\/10.3390\/cancers11081126 (2019).","DOI":"10.3390\/cancers11081126"},{"key":"75155_CR32","doi-asserted-by":"publisher","first-page":"12102","DOI":"10.3390\/ijms252212102","volume":"25","author":"I Er","year":"2024","unstructured":"Er, I. & Boz Er, A. B. Hedgehog pathway is a regulator of stemness in HER2-positive trastuzumab-resistant breast cancer. Int. J. Mol. Sci. 25, 12102 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"75155_CR33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/bcr3401","volume":"15","author":"M Hui","year":"2013","unstructured":"Hui, M. et al. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy. Breast cancer Res. 15, 203 (2013).","journal-title":"Breast cancer Res."},{"key":"75155_CR34","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/CAD.0000000000000584","volume":"29","author":"X Li","year":"2018","unstructured":"Li, X. et al. Sonic hedgehog and Wnt\/\u03b2-catenin pathways mediate curcumin inhibition of breast cancer stem cells. Anti-cancer drugs 29, 208\u2013215 (2018).","journal-title":"Anti-cancer drugs"},{"key":"75155_CR35","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1369\/jhc.2010.955856","volume":"58","author":"K Yuan","year":"2010","unstructured":"Yuan, K. et al. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues.  J. Histochem. Cytochem. 58, 857\u2013870 (2010).","journal-title":"J. Histochem. Cytochem."},{"key":"75155_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep32770","volume":"6","author":"M Kim","year":"2016","unstructured":"Kim, M. et al. KIF3A binds to \u03b2-arrestin for suppressing Wnt\/\u03b2-catenin signalling independently of primary cilia in lung cancer. Sci. Rep. 6, 32770 (2016).","journal-title":"Sci. Rep."},{"key":"75155_CR37","doi-asserted-by":"publisher","unstructured":"Nishita, M. et al. Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-016-0028-x (2017).","DOI":"10.1038\/s41598-016-0028-x"},{"key":"75155_CR38","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s13046-023-02850-7","volume":"42","author":"UK Soni","year":"2023","unstructured":"Soni, U. K., Jenny, L. & Hegde, R. S. IGF-1R targeting in cancer - does sub-cellular localization matter? J. Exp. Clin. Cancer Res 42, 273 (2023).","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"75155_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2020.111035","volume":"518","author":"BE Forbes","year":"2020","unstructured":"Forbes, B. E., Blyth, A. J. & Wit, J. M. Disorders of IGFs and IGF-1R signaling pathways. Mol. Cell. Endocrinol. 518, 111035 (2020).","journal-title":"Mol. Cell. Endocrinol."},{"key":"75155_CR40","doi-asserted-by":"publisher","unstructured":"Biello, F. et al. Insulin\/IGF axis in breast cancer: clinical evidence and translational insights. Biomolecules https:\/\/doi.org\/10.3390\/biom11010125 (2021).","DOI":"10.3390\/biom11010125"},{"key":"75155_CR41","doi-asserted-by":"publisher","first-page":"4015","DOI":"10.1038\/s41388-019-0694-9","volume":"38","author":"A Choucair","year":"2019","unstructured":"Choucair, A. et al. The arginine methyltransferase PRMT1 regulates IGF-1 signaling in breast cancer. Oncogene 38, 4015\u20134027 (2019).","journal-title":"Oncogene"},{"key":"75155_CR42","doi-asserted-by":"publisher","first-page":"8236","DOI":"10.1111\/jcmm.15499","volume":"24","author":"Q Zhang","year":"2020","unstructured":"Zhang, Q. et al. lncRNA NR2F1-AS1 promotes breast cancer angiogenesis through activating IGF-1\/IGF-1R\/ERK pathway. J. Cell. Mol. Med. 24, 8236\u20138247 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"75155_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.990398","volume":"12","author":"AE Obr","year":"2022","unstructured":"Obr, A. E. et al. Breast tumor IGF1R regulates cell adhesion and metastasis: alignment of mouse single cell and human breast cancer transcriptomics. Front. Oncol. 12, 990398 (2022).","journal-title":"Front. Oncol."},{"key":"75155_CR44","doi-asserted-by":"publisher","unstructured":"Gao, X. K. et al. VAPB-mediated ER-targeting stabilizes IRS-1 signalosomes to regulate insulin\/IGF signaling. Cell Discov. https:\/\/doi.org\/10.1038\/s41421-023-00576-6 (2023).","DOI":"10.1038\/s41421-023-00576-6"},{"key":"75155_CR45","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.1074\/jbc.M110508200","volume":"277","author":"N Begum","year":"2002","unstructured":"Begum, N., Sandu, O. A., Ito, M., Lohmann, S. M. & Smolenski, A. Active Rho Kinase (ROK-\u03b1) associates with insulin receptor substrate-1 and inhibits insulin signaling in vascular smooth muscle cells. J. Biol. Chem. 277, 6214\u20136222 (2002).","journal-title":"J. Biol. Chem."},{"key":"75155_CR46","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.3390\/cancers14246247","volume":"14","author":"C Chattopadhyay","year":"2022","unstructured":"Chattopadhyay, C. et al. Targeting IRS-1\/2 in uveal melanoma inhibits in vitro cell growth, survival and migration, and in vivo tumor growth. Cancers 14, 6247 (2022).","journal-title":"Cancers"},{"key":"75155_CR47","first-page":"1","volume":"63","author":"G Gorgisen","year":"2017","unstructured":"Gorgisen, G., Gulacar, I. M. & Ozes, O. N. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation. Cell. Mol. Biol. (Noisy-le.-Gd., Fr.) 63, 1\u20135 (2017).","journal-title":"Cell. Mol. Biol. (Noisy-le.-Gd., Fr.)"},{"key":"75155_CR48","doi-asserted-by":"publisher","first-page":"e76183","DOI":"10.7554\/eLife.76183","volume":"11","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. FER-mediated phosphorylation and PIK3R2 recruitment on IRS4 promote AKT activation and tumorigenesis in ovarian cancer cells. Elife 11, e76183 (2022).","journal-title":"Elife"},{"key":"75155_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112615","volume":"403","author":"P Hao","year":"2021","unstructured":"Hao, P. et al. IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K\/Akt and Ras-MAPK pathways. Exp. Cell Res. 403, 112615 (2021).","journal-title":"Exp. Cell Res."},{"key":"75155_CR50","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1007\/s00535-018-1432-8","volume":"53","author":"P Sanmart\u00edn-Salinas","year":"2018","unstructured":"Sanmart\u00edn-Salinas, P. et al. Insulin receptor substrate-4 is overexpressed in colorectal cancer and promotes retinoblastoma-cyclin-dependent kinase activation. J. Gastroenterol. 53, 932\u2013944 (2018).","journal-title":"J. Gastroenterol."},{"key":"75155_CR51","doi-asserted-by":"publisher","first-page":"e73327","DOI":"10.1371\/journal.pone.0073327","volume":"8","author":"VS Margalet","year":"2013","unstructured":"Margalet, V. S., Hoxhaj, G., Dissanayake, K. & MacKintosh, C. Effect of IRS4 levels on PI 3-kinase signalling. PloS one 8, e73327 (2013).","journal-title":"PloS one"},{"key":"75155_CR52","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.bbrc.2023.09.036","volume":"680","author":"M Ahmed","year":"2023","unstructured":"Ahmed, M., Biswas, T. & Mondal, S. The strategic involvement of IRS in cancer progression. Biochem. Biophys. Res. Commun. 680, 141\u2013160 (2023).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75155-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75155-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75155-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:05:22Z","timestamp":1786489522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75155-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75155"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75155-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"25 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8221"}}